Reference health
Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: Eastern equine and western equine encephalitis
1 of 40 checkable references need attention · checked 2026-07-22
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
8 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1128/AEM.26.4.485-488.1973
The 39 checked references that resolve
resolves10.4269/ajtmh.2007.76.285
HUMAN EASTERN EQUINE ENCEPHALITIS IN MASSACHUSETTS: PREDICTIVE INDICATORS FROM MOSQUITOES COLLECTED AT 10 LONG-TERM TRAP SITES, 1979–2004
resolves10.4049/jimmunol.63.3.313
Immunization of Laboratory Workers with Purified Venezuelan Equine Encephalomyelitis Vaccine
resolves10.1128/IAI.4.1.37-43.1971
Cross-Protection in Hamsters Immunized with Group A Arbovirus Vaccines
resolves10.1016/j.vaccine.2009.02.090
Immune interference after sequential alphavirus vaccine vaccinations
resolves10.4269/ajtmh.1970.19.119
An Inactivated Eastern Equine Encephalomyelitis Vaccine Propagated in Chick-Embryo Cell Culture
resolves10.4269/ajtmh.1971.20.146
Inactivated Western Equine Encephalomyelitis Vaccine Propagated in Chick Embryo Cell Culture
resolves10.4269/ajtmh.1988.39.593
Isolation of a Newly Recognized Bunyamwera Serogroup Virus from a Febrile Human in Panama
resolves10.1016/j.vaccine.2005.12.055
Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine
resolves10.1086/514240
Immunologic Interference from Sequential Administration of Live Attenuated Alphavirus Vaccines
resolves10.1073/pnas.81.15.4702
An evolutionary tree relating eight alphaviruses, based on amino-terminal sequences of their glycoproteins.
resolves10.1016/j.jviromet.2009.11.006
A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV)
resolves10.1016/j.vaccine.2011.01.087
Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV
resolves10.1016/j.vaccine.2009.02.062
Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus
resolves10.1371/journal.pone.0030898
Induction of Heterosubtypic Cross-Protection against Influenza by a Whole Inactivated Virus Vaccine: The Role of Viral Membrane Fusion Activity
resolves10.1016/j.vetimm.2008.08.007
Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine
resolves10.1016/j.vaccine.2010.01.065
Co-administration of viral vector-based vaccines suppresses antigen-specific effector CD8 T cells
resolves10.1016/j.vaccine.2009.05.017
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen
resolves10.1016/0264-410X(95)00168-Z
Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine
resolves10.1016/j.vaccine.2011.02.037
Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study
resolves10.1016/j.vaccine.2011.01.071
Sex differences in the vaccine-specific and non-targeted effects of vaccines
resolves10.1016/j.vaccine.2010.07.026
Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly
resolves10.1186/1471-2334-7-120
Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study
resolves10.1093/ije/23.5.1078
Sex Differences in the Humoral Antibody Response to Live Measles Vaccine in Young Adults
resolves10.1001/archinternmed.2008.513
Half- vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005)
resolves10.1590/S1413-86702009000300013
Reference range for T lymphocytes populations in blood donors from two different regions in Brazil
resolves10.1111/j.1365-2249.2007.03573.x
Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals
resolves10.1007/s10522-008-9138-6
The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of age
resolves10.1038/gene.2009.12
Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis
resolves10.1586/erv.11.73
Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference
resolves10.1016/j.vaccine.2009.01.005
The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants
resolves10.4161/hv.6.11.12852
Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old
resolves10.1016/j.vaccine.2011.05.019
Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella
resolves10.1016/j.vaccine.2009.12.080
Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: Using PRNT50 as an endpoint for immunogenicity
resolves10.4269/ajtmh.2009.08-0625
Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance
The 8 references without a DOI — listed, not checked
no DOI — not checkedAlphaviruses
no DOI — not checkedAlphaviruses
no DOI — not checkedAlphaviral encephalitides
no DOI — not checkedBiodefense and special pathogen vaccines
no DOI — not checkedCenters for disease control and prevention. General recommendations on immunization: recommendations of the advisory committee on immunization practices (ACIP). MMWR 2011; 60(RR02):1–60.
no DOI — not checkedMedical countermeasures
no DOI — not checkedSAS Institute Incorporated. Cary, NC;, 2009.
no DOI — not checkedPrevnar 13 [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Corp; Dec 2011.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.vaccine.2012.09.049"><img src="https://citestamp.com/citestamped/10.1016/j.vaccine.2012.09.049/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.vaccine.2012.09.049)